September 6, 2024 8:03am

Momentum and volatility have left many investors questioning share pricing after August lows

My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today!

Never leave an investor uninformed

The jobs report showed payrolls grow by 142,000 in August, less than the161,000 expected by analysts However, the unemployment rate edged down to 4.2%, in line with expectations.

Remember that overnight and pre-open actions’ futures and markets doesn’t necessarily translate into actual trading in today’s market session.

My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today!

 

Friday: The pre-open Dow futures are DOWN -0.19% or (-77 points), the S&P futures are DOWN -0.27% or (-14 points) and the Nasdaq futures are DOWN -0.38% or (-72 points)

  • Futures fell on Friday as investors look to Friday’s key jobs report for further clues about the state of the U.S. economy,
  • European stocks were lower,
  • Asia-Pacific markets mostly fall.

 

Henry’omics:

We need to more than consider the economic environment to comprehend the micro re “our” universe of cell and gene therapy companies …

Thursday: The Dow closed DOWN -219.22 points or -0.54%, the S&P closed DOWN -16.66 points or -0.30% while the Nasdaq closed UIP +43.37 points or +0.25%

Thursday’s advance/decline line ended with a negative at the close of 15 incliner, 18 decliners and 2 flats

“Despite concerns stemming from the recent labor data, markets remain optimistic that the Fed will begin lowering interest rates by at least a quarter-percentage point at the conclusion of the September policy meeting. <CNBC>

Economic Data Docket: August nonfarm payrolls report at 8:30 a.m.; economists are calling for nonfarm payrolls growth of 161,000 and a slight decline in the unemployment rate to 4.2%.

 

Thursday’s RegMed Investors (RMi) Closing bell: “risks are riskier skewed to the downside as expectation could experience even more volatility.” … https://www.regmedinvestors.com/articles/13603

 

Q3/24:

  • September – 3 negative close
  • August – I neutral, 10 positive and 11 negative closes
  • July: 1 market holiday. 1 day off, 6 negative, 1 neutral and 12 positive closes

 

Companies in my headlights – It’s your decision; I provide ideas and context:

I post about “indication intelligence” looking toward investment conferences … to assist investors with insight into sector vulnerabilities and strengths. A dictionary definition of “indicate” refers to something less than a certainty; an indication could be a signal of being oversold or overbought, a recommendation, or grounds for inferring or a basis for believing.

Yet again, I am passing on forecasting the daily indications as non-farms jobs data expectation in the aftermarket fluctuated while the pre-open waits for the all-clear alarm …  it is still a mix of ups, downs and just unknowns.

 

The BOTTOM LINE: the cell and gene therapy sector continues to struggle …

Think of this market and “our” universe as a game of shuts and ladders or sometimes monopoly … and follow RMi’s “interchanges” to gain profit moves or recoup losses – eat the popcorn and ponder ANY moves!

  • Short on words, long on being Judicious!

 

Ponder this quote, “"I think if tomorrow's <Friday’s job> data comes in cool or soft compared to expectations, there will be a negative reaction in the market and likely further selling in a lot of those mega cap names that have led us up to this point." <SoFi head of investment strategy Liz Young Thomas>

 

Welcome to my world of defining the “grey’ in our universe!

  • Right up front, “I also hate to be so negative or contrarian but, this is a NO spin zone and facts are its product; I can always be WRONG but … I am mostly EARLY!”
  • The sector is what it is, until it isn’t and even then, it doesn’t seem to be… as NOT much changes as the sector’s share pricing rides the waves of volatility, algorithms, electronic trading and short covering.
  • I am more frequently right than consequentially wrong; if I wanted to be liked, I wouldn’t have been an analyst/journalist.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. All investments are subject to risks. Investors should consider investment objectives.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.  Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and it’s or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.

Henry McCusker, the editor and publisher of RegMed Investors could hold or have positions securities referred to in this publication and he will NOTIFY investors of holdings.